Raymond James Financial Services Advisors Inc. lowered its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 71.5% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,907 shares of the company’s stock after selling 24,850 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Acadia Healthcare were worth $473,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Aperio Group LLC raised its stake in Acadia Healthcare by 20.4% in the second quarter. Aperio Group LLC now owns 28,817 shares of the company’s stock valued at $1,423,000 after purchasing an additional 4,891 shares in the last quarter. Russell Investments Group Ltd. raised its stake in Acadia Healthcare by 17.3% in the second quarter. Russell Investments Group Ltd. now owns 259,916 shares of the company’s stock valued at $12,836,000 after purchasing an additional 38,267 shares in the last quarter. Public Employees Retirement Association of Colorado raised its stake in Acadia Healthcare by 0.9% in the second quarter. Public Employees Retirement Association of Colorado now owns 17,798 shares of the company’s stock valued at $879,000 after purchasing an additional 160 shares in the last quarter. World Asset Management Inc acquired a new position in Acadia Healthcare in the second quarter valued at about $242,000. Finally, Retirement Systems of Alabama acquired a new position in Acadia Healthcare in the second quarter valued at about $7,091,000.

A number of research analysts recently commented on the company. Cantor Fitzgerald dropped their price target on Acadia Healthcare from $48.00 to $39.00 and set a “neutral” rating for the company in a research note on Tuesday, October 24th. Craig Hallum reaffirmed a “buy” rating and issued a $41.00 price target (down previously from $65.00) on shares of Acadia Healthcare in a research note on Thursday, October 26th. Zacks Investment Research downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, October 2nd. Bank of America dropped their price target on Acadia Healthcare from $60.00 to $52.00 and set a “buy” rating for the company in a research note on Wednesday, October 25th. Finally, Deutsche Bank downgraded Acadia Healthcare from a “buy” rating to a “hold” rating and dropped their price target for the company from $60.00 to $37.00 in a research note on Wednesday, October 25th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and nine have issued a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $45.15.

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) opened at $31.09 on Thursday. The firm has a market capitalization of $2,781.45, a PE ratio of 13.82, a PEG ratio of 1.17 and a beta of 0.90. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.36 and a current ratio of 1.36. Acadia Healthcare Company, Inc. has a twelve month low of $26.92 and a twelve month high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Tuesday, October 24th. The company reported $0.58 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.65 by ($0.07). The firm had revenue of $716.70 million for the quarter, compared to the consensus estimate of $728.86 million. Acadia Healthcare had a return on equity of 8.57% and a net margin of 6.07%. The business’s revenue for the quarter was down 2.4% on a year-over-year basis. During the same quarter last year, the firm posted $0.58 earnings per share. research analysts anticipate that Acadia Healthcare Company, Inc. will post 2.23 EPS for the current year.

TRADEMARK VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/12/07/raymond-james-financial-services-advisors-inc-reduces-stake-in-acadia-healthcare-company-inc-achc.html.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.